Regent Pacific Group Limited
HK$0.44
1
+HK$0+0% Tuesday 07:59
Statistics
Day High
0.44
Day Low
0.38
52W High
0.86
52W Low
0.35
Volume
170,000
Avg. Volume
67,727
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-
Dividends
0%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
30JunExpected
Expected EPS
0
Actual EPS
0.0006
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 575.HK. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
GSK
GSK
Mkt Cap89.55B
Pfizer
PFE
Mkt Cap164.39B
Novartis
NVS
Mkt Cap244.75B
Merck
MRK
Mkt Cap300.25B
Johnson & Johnson
JNJ
Mkt Cap399.26B
Abbvie
ABBV
Mkt Cap346.75B
AMGEN
AMGN
Mkt Cap179.38B
Bristol-Myers Squibb
BMY
Mkt Cap101.27B
Sanofi
SNY
Mkt Cap141.43B
Astrazeneca
AZN
Mkt Cap271.67B
About
Endurance RP Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in the People's Republic of China, Europe, Hong Kong, and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management and corporate finance services. The company was formerly known as Regent Pacific Group Limited and changed its name to Endurance RP Limited in June 2021. Endurance RP Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.
Show more...
CEO
Jamie Alexander Gibson
Employees
17
Country
KY
ISIN
KYG3042R1314